You're lost in a hundred names.
Ozempic, Wegovy, Mounjaro, semaglutide, tirzepatide, retatrutide… You can't tell what's what, how they differ, or where to start. Every article assumes you already know.
Everyone is talking about GLP-1 peptides. Almost no one actually explains them to you. This free beginner's guide does — no hype, no jargon, nothing to sell you.
Ozempic, Wegovy, Mounjaro, semaglutide, tirzepatide, retatrutide… You can't tell what's what, how they differ, or where to start. Every article assumes you already know.
Every "guide" you find is an influencer promising a miracle or someone trying to close a sale. You don't know who to trust — or how to tell honest information from a sales pitch.
This touches your health. You worry about missing a side effect nobody warned you about, not really understanding the risks, or making an important decision without the full picture.
You don't need to study medicine to understand this. You need a map. And nobody has handed you one yet.
Instead of memorizing a chaotic list of names, you learn a single progression. Semaglutide activates one receptor. Tirzepatide, two. Retatrutide, three. A three-step ladder. The moment you see it, the whole landscape clicks into place in your head.
First you understand why it works — the biology — and only then the what falls into place. That's what this guide does, and what almost no other source bothers to do.
Peptidonomy is a science education and outreach project on peptides. We don't sell compounds or treatments. Our only bet: in a field full of noise, hype and rush, honest, well-explained information is the most valuable thing there is. This guide is exactly that — and it's only the beginning.
Download The Beginner's Guide to GLP-1 Peptides for free and take the first step: understanding.